Skip to main content
. 2020 Aug 18;36(11):1344–1354. doi: 10.1007/s12264-020-00557-9

Fig. 6.

Fig. 6

Enhancement of NMDA currents by CCL2/CCR2 via the Cox-2 pathway. A, B Perfusion of NMDA (50 μmol) at a holding potential of –40 mV induces a robust inward current which is increased by perfusion with CCL2. The enhancement of NMDA currents by CCL2 is partly blocked by NS398 (10 μm), a Cox-2 inhibitor. *P < 0.05, n = 5.